The Data Management and Analysis Core (Core A) will interact importantly with each of the 4 projects, and the Scientific Core B. We have developed a detailed plan to optimize the synergy and interactions among the projects, cores and personnel involved in the studies proposed in this U19 application by the Stanford Alliance for Food Allergy Research (SAFAR) for a coordinated data analysis strategy. Notably, the members of the SAFAR team are already interacting scientifically. Accordingly, should this application be funded, the proposed work to advance our understanding of the pathology of peanut allergy, and the mechanisms that contribute to tolerance in this disorder, will represent a continuation and substantial expansion of these ongoing collaborative efforts. The Data Management and Analysis Core has three Specific Aims:
Aim 1 : Provide data analysis and statistical support for the phase 2 clinical trial of Project 1, evaluating the primary endpoint of induction of tolerance in peanut allergic patients treated with oral immunotherapy (OIT), and also analyzing ongoing safety data collected in the course of the trial;
Aim 2 : Provide integrated and coordinated statistical analysis of the clinical and immunological assay data that will be collected by Projects 1, 2, 3, 4, and the Scientific Core B, to attempt to identify immune system features that are predictive of whether or not peanut allergic patients will be tolerized by peanut OIT, and to attempt to identify immune system features that can be used to identify patients at increased risk of adverse reactions to OIT;, Aim 3: Provide and maintain a database organizing the data obtained in Projects 1, 2, 3,4 and the Scientific Core B, to facilitate data sharing with other investigators when the initial analysis of the SAFAR project is completed.

Public Health Relevance

This Core will help to ensure that the clinical outcomes of this phase 2 trial of oral immunotherapy for peanut allergy will be analyzed rigorously, and that analysis of the data from the panel of both conventional and novel immunological assays will be coordinated to define cellular mechanisms correlated with the development of tolerance to peanut allergens. This analysis may also highlight immune system features to monitor to optimize the safety and efficacy of oral immunotherapy for this very serious disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI104209-02
Application #
8605851
Study Section
Special Emphasis Panel (ZAI1-PA-I)
Project Start
Project End
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
2
Fiscal Year
2014
Total Cost
$91,570
Indirect Cost
$33,245
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Syed, Aleena; Garcia, Marco A; Lyu, Shu-Chen et al. (2014) Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol 133:500-10
Galli, Stephen J (2014) Rethinking the potential roles of mast cells in skin wound healing and bleomycin-induced skin fibrosis. J Invest Dermatol 134:1802-4
Manohar, Monali; Nadeau, Kari C (2014) The Potential of Anti-IgE in Food Allergy Therapy. Curr Treat Options Allergy 1:145-156
Starkl, Philipp; Marichal, Thomas; Galli, Stephen J (2013) PLA2G3 promotes mast cell maturation and function. Nat Immunol 14:527-9